Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 3.29
(4.44%)
CNY 3.29
(4.44%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.31 Billion CNY | -7.5% |
| 2022 | 1.42 Billion CNY | -6.67% |
| 2021 | 1.52 Billion CNY | 321.28% |
| 2020 | 362.03 Million CNY | 704.51% |
| 2019 | 45 Million CNY | 4499999900.0% |
| 2018 | 1.00 CNY | 13421772900.0% |
| 2017 | - CNY | 100.0% |
| 2016 | -35.63 Million CNY | -812.8% |
| 2015 | 5 Million CNY | 499999898.14% |
| 2014 | 1.00 CNY | -100.0% |
| 2013 | 18.5 Million CNY | -64.42% |
| 2012 | 52 Million CNY | -27.78% |
| 2011 | 72 Million CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 6.78 Million CNY | 303.4% |
| 2008 | 1.68 Million CNY | -51.04% |
| 2007 | 3.43 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 538.92 Million CNY | -55.23% |
| 2024 Q1 | 1.21 Billion CNY | -3.46% |
| 2024 Q2 | 1.2 Billion CNY | -0.82% |
| 2023 FY | 1.31 Billion CNY | -7.5% |
| 2023 Q1 | 1.52 Billion CNY | 7.1% |
| 2023 Q4 | 1.31 Billion CNY | -15.16% |
| 2023 Q2 | 1.53 Billion CNY | 0.69% |
| 2023 Q3 | 1.55 Billion CNY | 1.1% |
| 2022 Q2 | 1.3 Billion CNY | -10.85% |
| 2022 Q3 | 1.32 Billion CNY | 1.61% |
| 2022 FY | 1.42 Billion CNY | -6.67% |
| 2022 Q1 | 1.46 Billion CNY | -4.1% |
| 2022 Q4 | 1.42 Billion CNY | 7.43% |
| 2021 Q4 | 1.52 Billion CNY | 2.03% |
| 2021 FY | 1.52 Billion CNY | 321.28% |
| 2021 Q1 | 796.28 Million CNY | 119.95% |
| 2021 Q2 | 969.83 Million CNY | 21.79% |
| 2021 Q3 | 1.49 Billion CNY | 54.12% |
| 2020 Q2 | 182.69 Million CNY | 87.26% |
| 2020 FY | 362.03 Million CNY | 704.51% |
| 2020 Q1 | 97.56 Million CNY | 116.8% |
| 2020 Q3 | 345.14 Million CNY | 88.92% |
| 2020 Q4 | 362.03 Million CNY | 4.89% |
| 2019 Q2 | 30 Million CNY | 201326591999999900.0% |
| 2019 FY | 45 Million CNY | 4499999900.0% |
| 2019 Q4 | 45 Million CNY | 50.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q3 | 30 Million CNY | 0.0% |
| 2018 Q2 | - CNY | -100.0% |
| 2018 Q3 | - CNY | -100.0% |
| 2018 FY | 1.00 CNY | 13421772900.0% |
| 2018 Q1 | 1.00 CNY | 13421772800.0% |
| 2018 Q4 | 1.00 CNY | 0.0% |
| 2017 Q1 | - CNY | 100.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 100.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q3 | 5 Million CNY | 0.0% |
| 2016 FY | -35.63 Million CNY | -812.8% |
| 2016 Q4 | -35.63 Million CNY | -812.8% |
| 2016 Q2 | 5 Million CNY | 0.0% |
| 2016 Q1 | 5 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q4 | 5 Million CNY | 0.0% |
| 2015 FY | 5 Million CNY | 499999898.14% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q2 | - CNY | -100.0% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q4 | 1.00 CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | 18.5 Million CNY | 0.0% |
| 2013 Q4 | 18.5 Million CNY | -50.0% |
| 2013 FY | 18.5 Million CNY | -64.42% |
| 2013 Q1 | 52 Million CNY | 0.0% |
| 2013 Q2 | 37 Million CNY | -28.85% |
| 2013 Q3 | 37 Million CNY | 0.0% |
| 2012 Q3 | 67 Million CNY | 0.0% |
| 2012 FY | 52 Million CNY | -27.78% |
| 2012 Q2 | 67 Million CNY | -6.94% |
| 2012 Q1 | 72 Million CNY | 0.0% |
| 2012 Q4 | 52 Million CNY | -22.39% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q4 | 72 Million CNY | 229.97% |
| 2011 Q2 | 19.55 Million CNY | 0.0% |
| 2011 FY | 72 Million CNY | 0.0% |
| 2011 Q3 | 21.82 Million CNY | 11.61% |
| 2010 Q1 | 6.78 Million CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q4 | - CNY | -100.0% |
| 2010 Q3 | 6.48 Million CNY | -4.42% |
| 2010 Q2 | 6.78 Million CNY | 0.0% |
| 2009 FY | 6.78 Million CNY | 303.4% |
| 2009 Q2 | 1.74 Million CNY | 0.0% |
| 2009 Q4 | 6.78 Million CNY | 288.92% |
| 2009 Q3 | 1.74 Million CNY | 0.0% |
| 2008 FY | 1.68 Million CNY | -51.04% |
| 2008 Q4 | 1.68 Million CNY | 0.0% |
| 2007 FY | 3.43 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |